Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-838P refers to a pseudogene of the U6 small nuclear RNA (snRNA) family, specifically the 838th annotated copy. U6 snRNA is a crucial component of the spliceosome, an RNA-protein complex responsible for pre-mRNA splicing[1][2]. Pseudogenes like RNU6-838P are non-functional genomic sequences that resemble functional snRNA genes but generally do not produce functional RNA or protein products due to mutations or lack of regulatory elements[3][4]. U6 snRNA pseudogenes, including RNU6-838P, are common in vertebrate genomes and are considered evolutionary remnants; they are not known to have direct biological or disease functions, are not therapeutic targets, and are not implicated in drug interactions or patient biomarkers[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 838, pseudogene (RNU6-838P).